N
Google TrendGME (1000+) — GameStop Stock Hits a New 52-Week High: What's Going On?
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:gme1000+pope francis200+nicolò tresoldi500+michael olise1000+bank of america fine1000+club brugge500+rb leipzig200+saudi news1000+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Whitehawk Therapeutics Re" (18 stories)

Top Headline Story

Whitehawk Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights
Lead StoryPR Newswiregeneral
Aug 6

Whitehawk Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights

<a href="https://news.google.com/rss/articles/CBMi3wFBVV95cUxPQk1FcURsQzVfeEU2LW5NcXFLYnM2LXFWcWcyMlZfcTB5Y2F4OXo4UFdIREI2QU5CME15UVBLRTlQMTJNeGtXUUk2UnBMb3QxZUFPRk9QWEVjRGk1bmctVFVucnlIbl9rOHZNamtRNHVQVlBXaDdSVEp5VWFKblFYRDhxeTV6VXh1Y0MtSUJUXzdfVk1nWHVXOEwwTXl6amlIdzc2alZFQ3lzak5UZHlrQmRoMXBfdUp2R0IyM2VJU2tzTmVkZkJNMTc4M29FV2tPbTAxR3pwTnpqTkVYcWQ4?oc=5" target="_blank">Whitehawk Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights</a>  <font color="#6f6f6f">PR Newswire</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
1000+18m ago

gme

GameStop Stock Hits a New 52-Week High: What's Going On?

Filter stories
200+18m ago

pope francis

The Myth of St. Francis

Filter stories
500+28m ago

nicolò tresoldi

Nicolò Tresoldi, chi è l'attaccante del Bruges che spaventa l'Inter in Champions League

Filter stories
1000+28m ago

michael olise

The Ballon d’Or doesn’t capture football’s wonder – Michael Olise is proof | Zito Madu

Filter stories

Search Results for "Whitehawk Therapeutics Re"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

17 stories displayed
Insiders At Whitehawk Therapeutics Sold US$2.5m In Stock, Alluding To Potential Weakness
Simply Wall Streetmarkets

Insiders At Whitehawk Therapeutics Sold US$2.5m In Stock, Alluding To Potential Weakness

<a href="https://news.google.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?oc=5" target="_blank">Insiders At Whitehawk Therapeutics Sold US$2.5m In Stock, Alluding To Potential Weakness</a>  <font color="#6f6f6f">Simply Wall Street</font>

Read Full StoryMore like this
Biocytogen and Whitehawk Therapeutics Enter Global Collaboration for Bispecific Antibody ADC Development
Business Wiregeneral

Biocytogen and Whitehawk Therapeutics Enter Global Collaboration for Bispecific Antibody ADC Development

<a href="https://news.google.com/rss/articles/CBMi8wFBVV95cUxNOGNFQ2daYVl5cFladU9wSGs1OFpjdTlVTUc3R0w5X3cxRFVqZHVIRE5PcWxXdjA5NVptZUVnekl2dE9KVll2TXFYQ3VaSTBROGpsMTBJXzdFNll1RTI0aGxFb29zSmdyN0U1YXdpZnlSeTlpVUE0aWpmR1R2R09qeUxqN0dfVExqSlRzSjg4WXlFM3EzSVN2Y0N2Rnk3S0duNGlVeUwtLTEyM3FHd2ZSekNtd3BwQUxiMGNQZm0zRTVoV1B0ejdSa1kwU3VpNGxyN05SakZqOGdFRlR3RjNONmxYaHBKRUVHdFFiREY2MklpYzg?oc=5" target="_blank">Biocytogen and Whitehawk Therapeutics Enter Global Collaboration for Bispecific Antibody ADC Development</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
Whitehawk swoops in for five ADCs via development deal with China's Biocytogen
Fierce Biotechworld

Whitehawk swoops in for five ADCs via development deal with China's Biocytogen

<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxQVHJoOGpmWnF3LWtpbmpOajNCd3U5Vk9seXFRU3ZIMFNiYnNwUThCb29rMkRSYzMzVHZCVmphUzV3SG5lVkhEMjFQWmgtTk5tUzJQN3BlRHp1YXhlYXhUYUF4bjExYmRPNnFIcjg4WkFIMlB1SF9mRm5FdC0tRjNQekxVTVNvOGZXT1lFQWRXMGJaSndBUHE4?oc=5" target="_blank">Whitehawk swoops in for five ADCs via development deal with China's Biocytogen</a>  <font color="#6f6f6f">Fierce Biotech</font>

Read Full StoryMore like this
Biocytogen and Whitehawk Therapeutics Partner to Develop Bispecific Antibody-Drug Conjugates Using Complementary Platform Technologies
BioPharm Internationaltech

Biocytogen and Whitehawk Therapeutics Partner to Develop Bispecific Antibody-Drug Conjugates Using Complementary Platform Technologies

<a href="https://news.google.com/rss/articles/CBMiiAJBVV95cUxPWjlNU1gtQ1dsTWpyZjE2aWtURklHWU5IejZxMDdaZ244VC0wWHZfQkNXbUNfT0ppelVldnhiNHhZdEtMamVKTEVES0NQd21WMEd0MVBKNjBZVmY3MHROd2NCQzBlWFdFTEZBOWhtVjBOamhmbXN4Ry03NS1BVHVjaXhMN3lUMUtpS01pc3kyZWUtTHplVXhYRHlHTS1nYThUcVMwVDQ1dXNxOVF5eUV5bENzN2xuMDBiM092MGFqa2h2Ukl5VEFubXAySWZ0TS0zNFBBMDBVc0lhVzhPbTdQcDd2aWJObU9BMWxHX25WQVJJRWVoY3RzVjFYT3E3c0pGQ0xyNUV6UnI?oc=5" target="_blank">Biocytogen and Whitehawk Therapeutics Partner to Develop Bispecific Antibody-Drug Conjugates Using Complementary Platform Technologies</a>  <font color="#6f6f6f">BioPharm International</font>

Read Full StoryMore like this
Whitehawk Therapeutics Presents Real-World Analyses Supporting PTK7 as a Durable ADC Target in EGFR Wild-Type Non-Small Cell Lung Cancer at WCLC 2026
WBOC TVworld

Whitehawk Therapeutics Presents Real-World Analyses Supporting PTK7 as a Durable ADC Target in EGFR Wild-Type Non-Small Cell Lung Cancer at WCLC 2026

<a href="https://news.google.com/rss/articles/CBMiqAJBVV95cUxNRmVxUFJ2dkhMQk5IWGw2TkUyRE1xcl9kZzBwVGlTcUROWDV3WHVMX0RTMmNpMXRQMjltaE9JcFlBZW5LdWlnZ2NxMi1YRFBxQ3Q5NFptclY2TkNpX1dQdlpyOHQtUmw5UU5rOXVaOWZTWEZ2aFZOQzNWMFNUdkVwNUhXUEU2Z2x5RGtOa0pyWURXUTVxbmJjTTFpYWx2YldfQWJNcF81RktBekdod3FPTWtsRDBlYmZSZk5uMWRUZ3NsUHlBaG5lc1dvMEdDMnY0cGNIZTI1ZXhnUmFYYUlhRURxclMybjBTSkVwcXdsRHl0ZTF0M2J6T042U3hfZHdkd1FTejljNkNEYkhrTjZHNndBYVdxbFQ0UmdlYjM0bkVsdEZjQmxkeg?oc=5" target="_blank">Whitehawk Therapeutics Presents Real-World Analyses Supporting PTK7 as a Durable ADC Target in EGFR Wild-Type Non-Small Cell Lung Cancer at WCLC 2026</a>  <font color="#6f6f6f">WBOC TV</font>

Read Full StoryMore like this
Whitehawk Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights
PR Newswiregeneral

Whitehawk Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights

<a href="https://news.google.com/rss/articles/CBMi3gFBVV95cUxNVUQ0WGZKQWRPTGxZSFhaa25lXzQ0MmRRazl0TklWeWlZZVl2aUFVbXlTVUVRSWY1SU5EblBEc0o1ZExaMlpha1dZOTh6Tnc1WURBbkRkSWFOZTUzX0VPbVRUeVB6eEJCaHBTOEFhVjhFMWNrZG5sdlpGSE5EdmdZLWo1YlplaHJZSmhjdkdwRFRia1ZpVzlCdDZmalBpSFprNGN6cjZmdDRaX0h3bERvZWdTa0REN1pRNUFVdU5LY0FjQU5GQW0yRzVuUjRQbFFwUWIwQTEyZVRjVHlLdFE?oc=5" target="_blank">Whitehawk Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights</a>  <font color="#6f6f6f">PR Newswire</font>

Read Full StoryMore like this
Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) Shares Fly 27% But Investors Aren't Buying For Growth
Simply Wall Streetgeneral

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) Shares Fly 27% But Investors Aren't Buying For Growth

<a href="https://news.google.com/rss/articles/CBMi7AFBVV95cUxNVlpIcm4tSGhWckdNRllFdlRWenZDLWZsWlFFSEdiY0JvTVQwb2lMSlZlRWlVNWpCNVZ1TVFFYmhSRldOMF9mMkdJaFkzYlQ5SXpSWDNqTDlsTDNaTUp0al9USTIxN2pWRE9XQlFBUFJFUUVMeGZ6RzVYOWowaXpSaFVVZzVTSElDMlpOLU52dDFYd0llQXQ2T1FIVFNiOFo4bnRuTXhWUk5tMllVQWJGYkxTUEUxaEFsUnJuSWtoeVQ1SlFiMmpQVlV3dU5kSXVrVnRSMy01bG4tTG1LYmJOaDJtZzVySnJwWEZMNNIB8gFBVV95cUxOUDhQcDFsalU1X2FhN3RyWHVOMWJROU1oR05BeENCLS0zRE53NERoZVB0TS1BbWkzWnJ6d21UTzA5ZjNHcl90T0VKVVhmODV2bi1kU1Bwa2JBbW81a0l4cTlIbHdrT0xRRk1CbHE0bWU4eFUxZlNJQzFpeUduYWtSbENLUGFQOHRacVdEZnNxY0dlZ0NWeXNVQlFiQzQydzBMUUdCdVpKT2hBUGRBV2MzWmZOR2tRd25ITlg0NmlGYkJlZ0gyT1VfMFlBTmJDZVFLQ05uV2g3NG1wam1Bdng4STczX2tvT0xucGpWZlVHeUNiZw?oc=5" target="_blank">Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) Shares Fly 27% But Investors Aren't Buying For Growth</a>  <font color="#6f6f6f">Simply Wall Street</font>

Read Full StoryMore like this
Akari Therapeutics Enters Strategic Research Collaboration with Whitehawk Therapeutics
GlobeNewswiregeneral

Akari Therapeutics Enters Strategic Research Collaboration with Whitehawk Therapeutics

<a href="https://news.google.com/rss/articles/CBMi7wFBVV95cUxNdnpLVWwyTEpydW9GbVEteVNhN3lHb3FMU2ZvelAtTVFpaUhPN1ExTjB0VERWZFM3T3RfUEtkTkZYVGZiZmozQlVCNkpfWTdweVVCakxXU1NNNzhuTUNONkRrZ0VNQ1lkTXhuVU9iMVo0TEVhMS1sdlA0VlhEZW5ybFV3dVdDMWpNaXVPeGxlbWRmWXkxOG5JMlBYOWd0M0hwd3ZXejhFV2tENXZkRDVSQUJNcjlEeVowTGR3U0tlZDJHUXN0QVk1eWFqbnB4WFlUa0ZBSU1WMWN6cEIwZ1d0Y3BQZUFnY2VIcy1RU2pLSQ?oc=5" target="_blank">Akari Therapeutics Enters Strategic Research Collaboration with Whitehawk Therapeutics</a>  <font color="#6f6f6f">GlobeNewswire</font>

Read Full StoryMore like this
Whitehawk Therapeutics: 'Hold' On Name Change, Next Generation PTK7 ADC Targeting (WHWK)
Seeking Alphageneral

Whitehawk Therapeutics: 'Hold' On Name Change, Next Generation PTK7 ADC Targeting (WHWK)

<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxQdzVjeDJYUTVUTzRhWWxMUVdGaUE3ME5xMEFiS29BWnJSS2M3V2RwYkk0UU9Xa2RoTVdacFRKQmdtaHNyVVZUYXhuNHdJUC1qOERpVVN1VzVSNFJoQkwyVVdSTkRMOGpCOTNtTUEyTGkzZTRWQVMzNkRaWF8zcTdRS3k0c0RaYW5xaV9qNVk1ajBUQlpEYUVVa0JEaGVzWVFQMlNDdGx3TnBPSFlXYXpfYzVyaHNfeUh5N24wTnNJbXBIY2M?oc=5" target="_blank">Whitehawk Therapeutics: 'Hold' On Name Change, Next Generation PTK7 ADC Targeting (WHWK)</a>  <font color="#6f6f6f">Seeking Alpha</font>

Read Full StoryMore like this
Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the AACR 2026
PR Newswiregeneral

Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the AACR 2026

<a href="https://news.google.com/rss/articles/CBMijwJBVV95cUxQYmFfYkxtMEVpbVJBb2JMUTBSSDl0eEJtLVpicVN3LWFodjZtRzdlb2JaS3dKNUppc2lEZDIxWldmV0VEOXg3VTIwSUx2SUE4RmlzNVczdV9zZGpZeXpxQ3NyOW83eG01Vldvb05HbmozcTFQWjZYVXhwcnNyQ2xEOUZ2cmtQWHdseHFKUlB0aFZRRFhZcFZLTjlUZmRaTlhpanZDRl9Ib181eURnTGs5S2RFWUhRbF9RWnJkVmlnamRJeUFTS1dJWVA3QVQ5YlNOQmU4TUwwVFVnWWtESHR0eGEya1VUY0FEeGpsNzhZZ2J4SlV6SU5ZdS1LOThZMDlHaDZMRzZyNGE3RDQ5d2pR?oc=5" target="_blank">Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the AACR 2026</a>  <font color="#6f6f6f">PR Newswire</font>

Read Full StoryMore like this
Biocytogen and Whitehawk partner to develop ADCs
Pharmaceutical Technologygeneral

Biocytogen and Whitehawk partner to develop ADCs

<a href="https://news.google.com/rss/articles/CBMijAFBVV95cUxOMzdOV3hlMWx3d2xZaUNuc1oyMFpQTlF0aEJGTDhRVk1zamF1UXZLVjNSOVM2VnhfWkw5Ym8yUVlxS01aMnQ0QXdWWXdETUVpVGVnYU9XcDJTRHhqVWQ1LTEyclpuNUxJTjduU3M4VUJsMlVLZTdIOHFkRzJ2NkVJNkcwS3p5WWZnUGJuWg?oc=5" target="_blank">Biocytogen and Whitehawk partner to develop ADCs</a>  <font color="#6f6f6f">Pharmaceutical Technology</font>

Read Full StoryMore like this
Whitehawk Therapeutics reports Q2 2026 net loss $16.6M; cash $190.0M funds into 2H 2028
TradingViewworld

Whitehawk Therapeutics reports Q2 2026 net loss $16.6M; cash $190.0M funds into 2H 2028

<a href="https://news.google.com/rss/articles/CBMi3wFBVV95cUxONjhlZERyc1RseXNOZlFzNWRKc3FxdWk3LUhRSk54aUN6eEk5cVlnTkNHejEwRDZaaHZ3UTRodjEyYlM0dm9SdWVIcEpRUF9PcWE5OENjOEV6bGhmM3hSVGl5M0U2YkVnOFp2WE5GWkhXYXdwYXdfaVd3TEU5Mk0tM1lCc0JqamtJYmF4Z0NiM0paaWxsQzZKVmV6b2g1NE1EMVJHODJRem1reXhuZ3dsaDVzcE9pTXFnWURRaTl2bExTWHluN05fUFdNVVhaREU2cGhwVkNESWgzWG55UmRN?oc=5" target="_blank">Whitehawk Therapeutics reports Q2 2026 net loss $16.6M; cash $190.0M funds into 2H 2028</a>  <font color="#6f6f6f">TradingView</font>

Read Full StoryMore like this
Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016
PR Newswireworld

Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016

<a href="https://news.google.com/rss/articles/CBMiiAJBVV95cUxPZERSZGltamFWZWRHb2F2emExMkdrdGw3SWdmTG1oNllKQUVVRk8ycU4tcFpfcFNfcG80ZVp4S3l0UUl2djduZlZQSm9sVTdNQnNvQTRhdGhrZHg0ckw2Q3FVbzJlNjlrNmdyOWlhcXB3alpwQmdUTVlvMjBUVEpiNzFYazlfNlg3RmN6UUVSVG4tYVlMSThZd2N6dlNrdS12dW1xdzZqMjF5VHJMUTJ5ZGFzT214TlpMMVhNYjlKMk5qR2R3bktYMFhqMHcxSkdCeU1GOTBFWFhzbUo5RnFIMmlPeFEyQ3JVNWhlczNKeTVPRDhITmV3bUJjYlJrT1B6THZXZ3ZxQmQ?oc=5" target="_blank">Whitehawk Therapeutics Advances to Clinical Stage with IND Clearance for HWK-007 and Announces IND Submission for HWK-016</a>  <font color="#6f6f6f">PR Newswire</font>

Read Full StoryMore like this
Whitehawk Therapeutics to Participate in Upcoming Investor Conferences
PR Newswiregeneral

Whitehawk Therapeutics to Participate in Upcoming Investor Conferences

<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxNcmh0SmV6UnVyTGl3OVAwQ1UtRnpmTGc4ZHpBWTdTLTlYX0ZHQUVjR1ltdi1ZRll1ejZWMmtuSDVaS3QyczhVQUhfX0FxQV9DdkpqZ3Jxd1Zvc1dzTVdnSlQwNEd0cmc4S1VVMC1KX0VvcTEtZXNXSTJ5TW0tc0llS0VCV1MzZlFveUlISm45Zzgzb01lVkdoZmZadVdMRWtVUWNMRmExbmhKMEhvR2JJLXJsM2dwMEd4T0x5czRXV2NUZHQ0?oc=5" target="_blank">Whitehawk Therapeutics to Participate in Upcoming Investor Conferences</a>  <font color="#6f6f6f">PR Newswire</font>

Read Full StoryMore like this
Whitehawk Therapeutics Presents Real-World Analyses Supporting MUC16 as a Durable ADC Target in Ovarian Cancer at IGCS 2026
PR Newswireworld

Whitehawk Therapeutics Presents Real-World Analyses Supporting MUC16 as a Durable ADC Target in Ovarian Cancer at IGCS 2026

<a href="https://news.google.com/rss/articles/CBMiiwJBVV95cUxNVHJ3cVUxNW5RX1I3ZGhQX08wUFI5Sk1XSW9kMHVTRUV3UnZoT21jTG9VWDdpQVFRUFFkYnIxVFo0cXQzWHRRblJ5UzdiX0ZKTGc3SlJIci1zLWIzZVFuYy1kSWx4RkVES0xQZTJOanpyalJnOXFLM2JIOVc3NGhQUzJTQzdlaDFySkp5ZmotRkhneW9TRnNjQTRvQnd2QktxdVJjbHVPbGZnYzJyeFRmZ3l5cWxhTktWTXNJTE96Umg3Z1lzWXV4T1FHaHMwdXVSbkJ6VlRfdlR3SkozUVk3cWNkeFphV0F4MHl0aDVUUy1Oa2U1UC1KRkF1Y0VfbWtNaWJORklVY29Oc1E?oc=5" target="_blank">Whitehawk Therapeutics Presents Real-World Analyses Supporting MUC16 as a Durable ADC Target in Ovarian Cancer at IGCS 2026</a>  <font color="#6f6f6f">PR Newswire</font>

Read Full StoryMore like this
Whitehawk Therapeutics (WHWK) Stock Price, News & Analysis
Stock Titanmarkets

Whitehawk Therapeutics (WHWK) Stock Price, News & Analysis

<a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTE93TkRZY0gtVFR3V3ZLakJJWnJOM1diaUJCaW8wRUdNalJabktXSTlQcFREejlhN2FkS01UcGxpSDR4WE53Y2VfVHFVVHpraXVJRkdj?oc=5" target="_blank">Whitehawk Therapeutics (WHWK) Stock Price, News & Analysis</a>  <font color="#6f6f6f">Stock Titan</font>

Read Full StoryMore like this
How Athletes Are Using Sound Therapy to Get Race Ready
Triathleteworld

How Athletes Are Using Sound Therapy to Get Race Ready

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxQNUs2ZktZUVhVY1p6MWZVUjBqQnBBRlFVcmlCTno5UFIxSDBHb0VUQUxqWFc0RDJiRko5b1hvd0ZZVEdZcGx2dUFUZ1d1SFM2M3FQRnBjV1psdUItdlBQaVF5WWJ0dWZxT0hRWHN2LXJyR2xldHVvUmNoWVpzZnZ5N1BOUFV3WndVVGY5Zk5vckRqR3Fic0E?oc=5" target="_blank">How Athletes Are Using Sound Therapy to Get Race Ready</a>  <font color="#6f6f6f">Triathlete</font>

Read Full StoryMore like this
"Whitehawk Therapeutics Re" — Live Google News Trends & Headlines